MARKET

CAI

CAI

Caris Life Sciences, Inc.
NASDAQ
27.77
+0.58
+2.13%
Opening 12:37 12/18 EST
OPEN
27.00
PREV CLOSE
27.19
HIGH
28.08
LOW
27.00
VOLUME
836.00K
TURNOVER
--
52 WEEK HIGH
42.50
52 WEEK LOW
22.86
MARKET CAP
7.84B
P/E (TTM)
-12.5355
1D
5D
1M
3M
1Y
5Y
1D
BLSH, SLMT, CAI: Cathie Wood Loads Up on Crypto and Healthcare Stocks, Trims a Consumer Tech Name
TipRanks · 1d ago
Reassessing Caris Life Sciences (CAI) Valuation After Recent Share Price Pullback and Short-Term Rebound
Simply Wall St · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Sunrun, PayPal, Caris
Reuters · 2d ago
BUZZ-Caris rises on $1.1 billion deal with Genentech
Reuters · 2d ago
Roche in pact with Caris to discover cancer drug targets
Seeking Alpha · 2d ago
BRIEF-Caris Life Sciences Announces Collaboration With Genentech
Reuters · 2d ago
Caris signs Genentech deal worth up to $1.1 billion for rare cancer targets
Reuters · 2d ago
Caris Life Sciences' Caris Discovery Signs License Agreement With Genentech To Identify, Validate Oncology Targets In Solid Tumor Tissue
Benzinga · 2d ago
More
About CAI
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Webull offers Caris Life Sciences, Inc. stock information, including NASDAQ: CAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAI stock methods without spending real money on the virtual paper trading platform.